Outcome Analysis of the Use of Cerament^® in Patients with Chronic Osteomyelitis and Corticomedullary Defects.

ABSTRACT:

Background

Chronic osteomyelitis (OM) is a progressive but mostly low-grade infection of the bones. The management of this disease is highly challenging for physicians. Despite systematic treatment approaches, recurrence rates are high. Further, functional and patient-reported outcome data are lacking, especially after osseous defects are filled with bioresorbable antibiotic carriers.

Objective

To assess functional and patient-reported outcome measures (PROM) following the administration of Cerament^® G or V due to corticomedullary defects in chronic OM.

Methods

We conducted a retrospective study from 2015 to 2020, including all patients who received Cerament^® for the aforementioned reason. Patients were diagnosed and treated in accordance with gl

SUBMITTER: Niemann M 

PROVIDER: S-EPMC9139791 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature